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1. Introduction 
It has been established that the 16-glucosiduronate 
metabolites of estriol comprise the major estriol com- 
ponent in pregnancy plasma [ 1 ] , urine [ 1,2] and 
amniotic fluid [3]. However, little is known about 
their physiological or pathological correlations. One 
reason is the fact that assays for individual metabolites 
of estriol either do not exist or are unsuitable for 
practical processing of large numbers of clinical sam- 
ples. The possibility that immune assays might provide 
a useful means of measuring individual estriol meta- 
bolites prompted us to develop and investigate various 
antigens. A non-specific 16a-glucosiduronate anti- 
serum has been reported [4]. This report describes 
radioimmune experiments in which picogram quan- 
tities of the 16-glucosiduronate metabolites of estriol 
were measured in the presence of vast excesses of 
estriol, other estrogens and/or their metabolites. 
Antibody specificity together with the natural pre- 
ponderance of the 16-glucosiduronate metabolites 
made possible their direct measurement in plasma 
and urine. 
2. Materials and methods 
The majority of these studies were performed 
using [ 3H] estriol- 16-glucosiduronate (15 Ci/mM) 
obtained as a gift from Dr U. Goebelsmann.* The 
crossreactivity with estriol-3-sulfate-16-glucosiduro- 
nate was determined with [3H] estriol-16-glucosi- 
* University of Southern California School of Medicine. 
North-Holland Publishing Company - Amsterdam 
duronate (50 Ci/mM) obtained from Amersham 
Searle. Non-radioactive steroids were obtained from 
Sigma Chemical Co. and Steraloids Inc. except for 
estriol-3-sulfate-16-glucosiduronate which was 
obtained from Dr U. Goebelsmann. 
2.1. Preparation of antigen 
A bovine serum albumin (BSA)-estriol-16-glucosi- 
duronate conjugate was prepared using methods 
similar to those previously described for estriol [5,6]. 
The conjugate was purified by initial dialyses against 
0.001 N HCl followed by dialysis against phosphate 
buffer (pH 7.6). Adult male albino rabbits were 
immunized with the steroid conjugate according to 
previously published schedules [6]. Antiserum 
obtained after a 2-month course of immunization 
was used in the following experiments. 
2.2. Radioimmune experiments 
Antibody binding curves were derived as follows: 
various dilutions of antiserum (0.3 ml) were incubated 
at 4°C with 110 pg (5000 cpm) of [3H] estriol-16- 
glucosiduronate. After 2 h, saturated ammonium 
sulfate (0.5 ml) was added. The solution was mixed, 
incubated for an additional 15 min and pelleted by 
centrifugation. A portion (0.6 ml) of the supernate 
was transferred to a scintillation counting vial to 
which was added 10 ml aquasol and 0.5 ml of 
deionized distilled water. Samples were counted for 
10 minutes in a Nuclear Chicago Mark II Liquid 
Scintillation Counter (50% counting efficiency for 
3H). 
The standard inhibition curve was derived from an 
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experiment in which 0.3 ml of an initial 1 : 120 anti- 
serum dilution bound 50% of added [3H] estriol-16- 
glucosiduronate. Known quantities of unlabeled 
estriol- 16-glucosiduronate or other steroids were 
dissolved in buffer and a 0.05 ml aliquot of each 
sample was allowed to pre-incubate for 30 min at 4°C 
with 0.3 ml of the selected dilution (1 : 120) of 
antiserum. The [‘HI estriol- 16-glucosiduronate was 
then added, mixed and incubated for an additional 
2 h. Separation of the bound fraction was accom- 
plished by saturated ammonium sulfate precipitation 
and a sample of the supernate was counted as 
described above. 
The procedure was modified slightly for handling 
plasma samples. To generate the standard curve 5 /..d 
of ‘stripped’ male plasma (7) containing known 
amounts of estriol-16-glucosiduronate and 0.3 ml of 
the 1 : 120 dilution of antiserum were incubated at 
4°C for 30 min. The subsequent steps were identical 
to those of assays in buffer described above. Unex- 
tracted plasma samples were obtained from several 
subjects and assayed directly for estriol-16-glucosi- 
duronate. To compare estriol-16-glucosiduronate 
levels with unconjugated estriol concentrations in the 
same subjects aliquots (200 ~1) of the plasma samples 
were also extracted with ether and assayed [8] for 
neutral estriol. 
Procedures for urine assay were identical to assays 
in buffer described above. 
3. Results 
3.1 . Sensitivity 
This was defined as the point on the standard 
curve distinguishable from 0.0 pg by two standard 
deviations and was 25 pg/tube. Intra-assay variance 
evaluated using ten duplicate determinations with 
values ranging from 50 to 1000 pg/tube gave 
coefficients of variation equal to or less than 15%. 
Interassay variance determined in eight duplicate 
determinations in two different assays resulted in a 
coefficient of variation of 20.5% [9] . 
3.2. Specificity 
The association constant (K,) was 3.48 X 10’ M-’ 
as determined by a Scatchard plot [lo] . Hapten 
inhibition results (fig.1, table 1) demonstrate that 
the antiserum is highly specific for estriol-16-glucosi- 
duronates. Cross-reactivity with estriol, various 
estriol metabolites and other steroids ranged from 
2.2% to less than 0.001% except for estriol-3-sulfate- 
16-glucosiduronate which was 100%. 
3.3. Plasma assays 
As shown in table 2, a significantly higher level 
07 < 0.005) of 16-glucosiduronate metabolites than 
estriol was measured in plasma samples from several 
subjects. The correlation coefficient between estriol 
measured in ether extracts of plasma and estriol- 16- 
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Fig. 1. Inhibition of [ ‘Hlestriol-16-glucosiduronate binding to estriol-16-glucosiduronate-BSA antisera by related steroid haptens. 
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Table 1 
Cross-reactivitya of estriol-16glucosiduronate antiserum with various steroids 
pg Steroid at 50% 
inhibition Cross-reactivity (%) 
Estriol-16-glucosiduronate 
Estriol-3-sulfate-16-glucosiduronate 
Estriol 
Estriol-3-sulfate 
Estriol-3-glucosiduronate 
Estradiol 
Estradiol-3-sulfate 
Estradiol-17glucosiduronate 
Estradiol-3-sulfate-l Il-glucosiduronate 
Estrone 
Estrone-S-sulfate 
Progesterone 
Cortisone 
175 100 
175 100 
8 x 10” 2.2 
1.16 x lo6 0.015 
4.38 x lo5 0.04 
5x lo4 0.35 
> 1 x lo6 < 0.0175 
> 1 x lo6 < 0.0175 
> 1 x lo6 < 0.0175 
1 x lo6 0.0175 
> 1 x 10’ < 0.001 
>l x 10’ < 0.001 
>1x107 < 0.001 
a Defined as pg of estriol at 50% inhibition X 100 
pg of other steroid at (50%) inhibition 
glucosiduronate assayed in unextracted plasma is 
0.884 (table 2). An extensive clinical study at differ- 
ent stages of gestation is in progress. 
Table 2 
Comparison of estriola and estriol-16-glucosiduronate levels 
Subject Estriol 
No. (nglml) 
1 27 
2 20 
3 28.7 
4 3.5 
5 4.0 
6 4.8 
7 3.0 
8 6.0 
9 7.7 
10 15.8 
11 13.8 
12 8.7 
13 10.2 
14 13.3 
15 5.1 
16 14.0 
17 19.4 
Estriol-16-gluco- 
siduronate 
(ng/ml) 
214 
152 
224 
19.8 
34.5 
27.0 
17.4 
87 
67.5 
54.0 
58.0 
65.5 
111 
60.5 
10.4 
84 
86 
Mean 12.058 80.741 
a Ether extracts 
3.4. Urine assays 
Samples of male urine, which did not inhibit [3H] 
estriol- 16glucosiduronate antiserum binding (unpu- 
blished data) were spiked with varying amounts of 
estrioLl6glucosiduronate and assayed (table 3). The 
levels of estriol-16-glucosiduronate measured did not 
significantly differ from the amount added. Having 
thus established the feasibility of a direct urine assay, 
samples of urine from non pregnant females were 
tested. The levels measured in 7 individuals varied 
from 0.3-20 ng/ml estriol-16-glucosiduronate. 
Table 3 
Accuracy of estriol-16-glucosiduronate measurements 
in spiked urine samples 
Estriol-16-glucosiduronate .Estriol-16-glucosiduronate 
added/tube (pg) measured/tube (pg) 
100 120 
200 200 
500 450 
1000 1000 
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4. Discussion 
These studies demonstrate a radioimmunoassay of 
the 16glucosiduronate metabolites of estriol directly 
in plasma and urine. As evidenced by inhibition 
experiments, none of the closely related metabolites 
cross-reacted appreciably with the antiserum. The 
cross-reactivity of the antiserum with estriol-3-sulfate- 
16-glucosiduronate is probably due to the fact that 
estriol-l6ar-glucosiduronate xceeds the antibody 
combining site which thus could be expected to 
recognize the estriol -16a-glucosiduronate portion of 
the diconjugate. This does contribute to the total 
16glucosiduronates in plasma. However, estriol-16a- 
glucosiduronate is the predominant estrogen meta- 
bolite in urine, the sulfoglucosiduronate constituting 
less than 4% [ 1 ] . 
The plasma levels of 16-glucosiduronate metabolites 
measured in this study were 667 times greater than 
those of estriol. These higher levels are consistent with 
the antiserum crossreactivity with estriol-3-sulfate-16- 
glucosiduronate and are further evidence of the mea- 
surement of the latter in the assay as well. The total 
16-glucosiduronate levels measured are about one and 
a half times those previously reported [ 11 following 
counter current distribution, enzyme hydrolysis 
chromatography and fluorometry. The difference may 
be less real than procedural. There is far less experi- 
mental manipulation in the simple immune assay 
described here. 
Simplified metabolite assays made feasible by 
specific metabolite antibodies have many obvious 
uses. The higher relative concentrations of estriol-16- 
glucosiduronates may allow detection of changes in 
fetoplacental function prior to the appearance of 
increasing levels of estriol, provided maternal liver 
and kidney functions are normal. 
Since conjugation occurs predominantly in the 
liver [ 11 ,121 and 16-glucosiduronates are excreted 
in the urine, abnormal plasma or urine metabolite 
levels may reflect impaired liver or kidney (glomerular) 
function. In fact derangement of estriol-3glucosi- 
duronation has been reported in patients with liver 
cholestasis [2] . Urine steroid metabolites such as 
estriol-16-glucosiduronate may signify more accurate 
ovulatory patterns than presently at hand. 
Before meaningful diagnostic/prognostic conclu- 
sions based on individual levels or ratios can be made 
native steroids and their metabolites have to be 
measured in a large diverse clinical population. Such 
studies are now being initiated in our laboratories. 
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